# Decitabine Combining Dexamethasone Versus Dexamethasone in Management of ITP

> **NCT03252457** · PHASE3 · UNKNOWN · sponsor: **Shandong University** · enrollment: 200 (estimated)

## Conditions studied

- Purpura, Thrombocytopenic, Idiopathic
- Immune Thrombocytopenia

## Interventions

- **DRUG:** Decitabine
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT03252457
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-01
- **Primary completion:** 2020-12-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2018-08-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03252457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03252457, "Decitabine Combining Dexamethasone Versus Dexamethasone in Management of ITP". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03252457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*